Treg-based Therapies to Induce Immune Tolerance in Transplantation & Autoimmunity

Time: 9:00 am
day: Day One

Details:

  • Lessons learned from Treg-directed therapies in liver transplantation (polyclonal Tregs vs low dose IL-2 therapy)
  • Engineered Tregs for the modulation of antigen-specific responses
  • Quell Therapeutics strategy to enhance Treg therapies

Speakers: